Cargando…

A European Competence Framework for Industrial Pharmacy Practice in Biotechnology

The PHAR-IN (“Competences for industrial pharmacy practice in biotechnology”) looked at whether there is a difference in how industrial employees and academics rank competences for practice in the biotechnological industry. A small expert panel consisting of the authors of this paper produced a biot...

Descripción completa

Detalles Bibliográficos
Autores principales: Atkinson, Jeffrey, Crowley, Pat, De Paepe, Kristien, Gennery, Brian, Koster, Andries, Martini, Luigi, Moffat, Vivien, Nicholson, Jane, Pauwels, Gunther, Ronsisvalle, Giuseppe, Sousa, Vitor, van Schravendijk, Chris, Wilson, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597173/
https://www.ncbi.nlm.nih.gov/pubmed/28975907
http://dx.doi.org/10.3390/pharmacy3030101
_version_ 1783263662611365888
author Atkinson, Jeffrey
Crowley, Pat
De Paepe, Kristien
Gennery, Brian
Koster, Andries
Martini, Luigi
Moffat, Vivien
Nicholson, Jane
Pauwels, Gunther
Ronsisvalle, Giuseppe
Sousa, Vitor
van Schravendijk, Chris
Wilson, Keith
author_facet Atkinson, Jeffrey
Crowley, Pat
De Paepe, Kristien
Gennery, Brian
Koster, Andries
Martini, Luigi
Moffat, Vivien
Nicholson, Jane
Pauwels, Gunther
Ronsisvalle, Giuseppe
Sousa, Vitor
van Schravendijk, Chris
Wilson, Keith
author_sort Atkinson, Jeffrey
collection PubMed
description The PHAR-IN (“Competences for industrial pharmacy practice in biotechnology”) looked at whether there is a difference in how industrial employees and academics rank competences for practice in the biotechnological industry. A small expert panel consisting of the authors of this paper produced a biotechnology competence framework by drawing up an initial list of competences then ranking them in importance using a three-stage Delphi process. The framework was next evaluated and validated by a large expert panel of academics (n = 37) and industrial employees (n “Research and Development”, ‘“Upstream” and “Downstream” Processing’, ; “Product development and formulation”, “Aseptic processing”, ; “Analytical methodology”, ; “Product stability”, and “Regulation”. The main area of disagreement was in the category “Ethics and drug safety” where academics ranked competences higher than did industrial employees.
format Online
Article
Text
id pubmed-5597173
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-55971732017-09-29 A European Competence Framework for Industrial Pharmacy Practice in Biotechnology Atkinson, Jeffrey Crowley, Pat De Paepe, Kristien Gennery, Brian Koster, Andries Martini, Luigi Moffat, Vivien Nicholson, Jane Pauwels, Gunther Ronsisvalle, Giuseppe Sousa, Vitor van Schravendijk, Chris Wilson, Keith Pharmacy (Basel) Project Report The PHAR-IN (“Competences for industrial pharmacy practice in biotechnology”) looked at whether there is a difference in how industrial employees and academics rank competences for practice in the biotechnological industry. A small expert panel consisting of the authors of this paper produced a biotechnology competence framework by drawing up an initial list of competences then ranking them in importance using a three-stage Delphi process. The framework was next evaluated and validated by a large expert panel of academics (n = 37) and industrial employees (n “Research and Development”, ‘“Upstream” and “Downstream” Processing’, ; “Product development and formulation”, “Aseptic processing”, ; “Analytical methodology”, ; “Product stability”, and “Regulation”. The main area of disagreement was in the category “Ethics and drug safety” where academics ranked competences higher than did industrial employees. MDPI 2015-07-29 /pmc/articles/PMC5597173/ /pubmed/28975907 http://dx.doi.org/10.3390/pharmacy3030101 Text en © 2015 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Project Report
Atkinson, Jeffrey
Crowley, Pat
De Paepe, Kristien
Gennery, Brian
Koster, Andries
Martini, Luigi
Moffat, Vivien
Nicholson, Jane
Pauwels, Gunther
Ronsisvalle, Giuseppe
Sousa, Vitor
van Schravendijk, Chris
Wilson, Keith
A European Competence Framework for Industrial Pharmacy Practice in Biotechnology
title A European Competence Framework for Industrial Pharmacy Practice in Biotechnology
title_full A European Competence Framework for Industrial Pharmacy Practice in Biotechnology
title_fullStr A European Competence Framework for Industrial Pharmacy Practice in Biotechnology
title_full_unstemmed A European Competence Framework for Industrial Pharmacy Practice in Biotechnology
title_short A European Competence Framework for Industrial Pharmacy Practice in Biotechnology
title_sort european competence framework for industrial pharmacy practice in biotechnology
topic Project Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597173/
https://www.ncbi.nlm.nih.gov/pubmed/28975907
http://dx.doi.org/10.3390/pharmacy3030101
work_keys_str_mv AT atkinsonjeffrey aeuropeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT crowleypat aeuropeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT depaepekristien aeuropeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT gennerybrian aeuropeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT kosterandries aeuropeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT martiniluigi aeuropeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT moffatvivien aeuropeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT nicholsonjane aeuropeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT pauwelsgunther aeuropeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT ronsisvallegiuseppe aeuropeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT sousavitor aeuropeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT vanschravendijkchris aeuropeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT wilsonkeith aeuropeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT atkinsonjeffrey europeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT crowleypat europeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT depaepekristien europeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT gennerybrian europeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT kosterandries europeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT martiniluigi europeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT moffatvivien europeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT nicholsonjane europeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT pauwelsgunther europeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT ronsisvallegiuseppe europeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT sousavitor europeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT vanschravendijkchris europeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology
AT wilsonkeith europeancompetenceframeworkforindustrialpharmacypracticeinbiotechnology